Table 1.
Information Concerning the Primers Used in This Study
| Primer Name | Sequence (5′→3′) | DNA Amplicon Size (bp) | Annealing Temperature (°C) | Reference |
|---|---|---|---|---|
| OXA-23-like | F: GATCGGATTGGAGAACCAGA R: ATTTCTGACCGCATTTCCAT |
501 | 53.2 | [23] |
| OXA-51-like | F:CTAATAATTGATCTACTCAAGTTAC R: GAATACTCCATTTGAACCARTGG |
988 | 55.1 | [24] |
| NDM | F: CGGAATGGCTCATCACGATC R: CGGAATGGCTCATCACGATC |
621 | 50 | [25] |
| IMP | F: GGAATAGAGTGGCTTAAYTCTC R: GGTTTAAYAAAACAACCACC |
232 | 55 | [25] |
| VIM | F: GATGGTGTTTGGTCGCATA R: CGAATGCGCAGCACCAG |
390 | 55 | [25] |
| KPC | F: CGTCTAGTTCTGCTGTCTTG R: CTTGTCATCCTTGTTAGGCG |
798 | 55 | [25] |
| ampC | F: AGGAGCTAATCATGCGATT R: CAAGCTTAGGATATGTTTGG |
1259 | 56 | [26] |
| CarO | F: GACAACTACAGCTTTACTTGCT R: ACACCAACTTTACCAACTGG |
711 | 57 | [23] |
| SPM | F:AAAATCTGGGTACGCAAACG R:ACATTATCCGCTGGAACAGG |
271 | 52 | [26] |
| AIM | F:CTGAAGGTGTACGGAAACAC R:GTTCGGCCACCTCGAATTG |
322 | 52 | [26] |
Abbreviation: CarO, carbapenem-associated resistance OMP.